Abstract
Background: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS+HIPEC) is an established treatment in patients with peritonitis carcinomatosis of colorectal cancer. However, severe complications are frequently reported. Muscle depletion is associated with impaired outcome after oncologic treatment. The goal of the current study was to determine the influence of severe skeletal muscle depletion in patients treated with CRS+HIPEC for peritoneal dissemination of colorectal cancer.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Clinical oncology (Royal College of Radiologists (Great Britain))
Paper Title
Journal
Date
